Altair to Announce First Quarter 2018 Financial Results on May 14, 2018
Apr 23, 2018 20:05 pm UTC| Business
TROY, Mich., April 23, 2018 -- Altair Engineering (Nasdaq:ALTR) will release its financial results for the first quarter of 2018, ended March 31, 2018, after the market close on Monday, May 14, 2018. On that day,...
Donegal Group Inc. Announces First Quarter 2018 Results
Apr 23, 2018 20:05 pm UTC| Business
MARIETTA, Pa., April 23, 2018 -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) today reported its financial results for the first quarter of 2018. The Company will hold a live conference call on Tuesday, April...
Tivity Health Reports First-Quarter 2018 Results and Affirms Financial Guidance
Apr 23, 2018 20:05 pm UTC| Business
REVENUES OF $150 MILLION AND DILUTED EPS OF $0.49 ANNOUNCES HIRING OF CHIEF BRAND OFFICER NASHVILLE, Tenn., April 23, 2018 -- Tivity Health, Inc. (NASDAQ:TVTY) today announced financial results for the first quarter...
Apr 23, 2018 20:05 pm UTC| Business
IRVINE, Calif., April 23, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, today announced a new management structure including the...
Woodward Reports Second Quarter Fiscal Year 2018 Results
Apr 23, 2018 20:05 pm UTC| Business
FORT COLLINS, Colo., April 23, 2018 -- Woodward, Inc. (NASDAQ:WWD) today reported financial results for its second quarter of fiscal year 2018 ending March 31, 2018. (All per share amounts are presented on a fully...
Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET
Apr 23, 2018 20:05 pm UTC| Business
HOLLISTON, Mass., April 23, 2018 -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first...
Atossa Genetics Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Apr 23, 2018 20:05 pm UTC| Business
SEATTLE, April 23, 2018 -- Atossa Genetics Inc. (ATOS) (“Atossa” or the “Company”), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast...